Adhesive interactions in the hematopoietic system: Regulation by cytokines

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 4, 1996, Pages 313-323

  Fernández, Mireya ^a   Minguell, José J ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; SCLEROPROTEIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

CELL ADHESION; CELL INTERACTION; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; NONHUMAN; SHORT SURVEY; STROMA CELL;

EID: 0029844560     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-44021     Document Type: Short Survey

References (136)

1. Zanjani ED, Wilson J, Adams JG. Obituary, Medhi Tavassoli, MD. 1933-1993. Exp Hematol 23:7, 1995.
2. Tavassoli M, Minguell JJ. Homing of hemopoietic progenitor cells to the marrow. Proc Soc Exp Biol Med 196:367-373, 1991.
3. Orkin SH. Hematopoiesis: How does it happen? Curr Opin Cell Biol 7:870-877, 1995.
4. Klein G. The extracellular matrix of the hematopoietic microenvironment. Experentia 51:914-926, 1995.
5. Funk PE, Kincade PW, Witte P. Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood 83:361-369, 1994.
6. + progenitor cells: potential regulatory checkpoints for cellular traffic. Leuk Lymphoma 14:19-28, 1994.
7. Long MW. Blood cell cytoadhesion molecules. Exp Hematol 20:288-301, 1992.
8. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 120:577-585, 1993.
9. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994.
10. Verfaillie C, Hurley R, Bhatia R, McCarthy JB. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit Rev Oncol Hematol 16:201-224, 1994.
11. Yoder MC, Williams DA. Matrix molecule interactions with hematopoietic stem cells. Exp Hematol 23:961-967, 1995.
12. Seshi B. Discovery of novel hematopoietic cell adhesion molecules from human bone marrow stromal cell membrane protein extracts by a new cell-blotting technique. Blood 83:2399-2409, 1994.
13. Patrick CW Jr., Juneja HS, Lee S, Schmalstieg FC, McIntire LV. Heterotypic adherence between human B-lymphoblastic and pre-B-lymphoblastic cells and marrow stromal cells is a biphasic event: Integrin very late antigen-4 mediates only the early phase of the heterotypic adhesion. Blood 85:168-178, 1995.
14. Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 81:112-121, 1993.
15. Gelin C, Aubrit F, Phalipon A, Raynal B, Cole S, Kaczorek M, Bernard A. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 8:3253-3259, 1989.
16. Dworzak MN, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A, Schöllhammer A, Steiner G, Ambros PF, Gadner H. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 83:415-425, 1994.
17. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235-243, 1990.
18. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdack DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattenach BM, Galli SJ, Suggs SV. Stem cell factor is encoded at the SL locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-218, 1990.
19. Andrews RG, Briddell RA, Appelbaum FR, McNiece IK. Stimulation of hematopoiesis in vivo by stem cell factor. Curr Opin Hematol 1:187-196, 1994.
20. Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R. Further phenotypic characterization an isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 79:3159-3167, 1992.
21. Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE. Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand. Blood 80:1679-1684, 1992.
22. Linenberger ML, Jacobsen FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL. Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol 23:1104-1114, 1995.
23. Fleischman RA, Simpson F, Gallardo T, Jin X, Perkins S. Isolation of endothelial-like stromal cells that express Kit ligand and support in vitro hematopoiesis. Exp Hematol 23:1407-1416, 1995.
24. Kinashi T, Springer TA. Steel factor and c-kit regulate cell-matrix adhesion. Blood 83:1033-1038, 1994.
25. Adachi S, Tsujimura T, Jippo T, Morimoto M, Isozaki K, Kasugai T, Nomura S, Kitamura Y. Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor. Exp Hematol 23:58-65, 1995.
26. Hu Z, Ma W, Uphoff CC, Quentmeier H, Drexler HG. c-kit expression in human megakaryoblastic leukemia cell lines. Blood 83:2133-2144, 1994.
27. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374-381, 1992.
28. Welham MJ, Schrader JW. Modulation of c-kit mRNA and protein by hemopoietic growth factors. Mol Cel Biol 11:2901-2904, 1991.
29. Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147:4224-4228, 1991.
30. + cells, via p55 TNF-α receptors. Blood 84:2506-2514, 1994.
31. + positive haemopoietic cells: Biology and clinical applications. Blood Rev 8:113-124, 1994.
32. Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78:2848-2853, 1991.
33. Delia D, Lampugnani MG, Resnati M, Dejana E, Aiello A, Fontanella E, Soligo D, Pierotti MA, Greaves MF. CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 81:1001-1008, 1993.
34. Lasky LA. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 64:113-139, 1995.
35. Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, Moore MAS, Asch AS. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 84:10-19, 1994.
36. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-Selectin. Blood 84:2554-2565, 1994.
37. Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T. CD34 and hematopoietic cell adhesion. Exp Hematol 23:816a, 1995.
38. Majdic O, Stöckl J, Pickl WF, Bohuslav J, Strobl H, Scheinecker C, Stockinger H, Knapp W. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 83:1226-1234, 1994.
39. + cells. Blood 80:429-436, 1992.
40. Satterthwaite AB, Borson R, Tenen DG. Regulation of the gene for CD34, a human hematopoietic stem cell antigen, in KG-1 cells. Blood 75:2299-2304, 1990.
41. Fackler MJ, Civin CI, May WS. Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem 267:17540-17546, 1992.
42. Perschl A, Lesley J, English N, Trowbridge I, Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25:495-501, 1995.
43. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 171:477-488, 1990.
44. Morimoto K, Robin E, Le Bousse-Kerdiles MC, Li Y, Clay D, Jasmin C, Smadja-Joffe F. CD44 mediates hyaluronan binding by human myeloid KG1a and KG1 cells. Blood 83:657-662, 1994.
45. Uff CR, Neame SJ, Isacke CM. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J Immunol 25:1883-1887, 1995.
46. Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF. Expression of CD44 molecules and CD44 ligands during human thymic fetal development: Expression of CD44 isoforms is developmentally regulated. Int Immunol 7:277-286, 1995.
47. Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ. Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 270:11567-11573, 1995.
48. McCourt PA, Ek B, Forsberg N, Gustafson S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269:30081-30084, 1994.
49. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-698, 1995.
50. Murakami S, Miyake K, June CH, Kincade PW, Hodes RJ. IL-5 induces a Pgp-1/CD44 bright B subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol 145:3618-3627, 1990.
51. Chiquet-Ehrismann R. Inhibition of cell adhesion by anti-adhesive molecules. Curr Opin Cell Biol 7:715-719, 1995.
52. Klein G, Beck S, Muller CA. Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J Cell Biol 123:1027-1035, 1993.
53. Sanchez-Mateos P, Campanero MR, Del Pozo MA, Sanchez-Madrid F. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod. Blood 86:2228-2239, 1995.
54. Klein G, Conzelmann S, Beck S, Timpl R, Muller CA. Perlecan in human bone marrow: A growth-factor presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol 14:457-465, 1995.
55. Chichester CO, Fernández M, Minguell JJ. Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts. Cell Adhes Commun 1:93-99, 1993.
56. Klein G, Muller CA, Tillet E, Chu ML, Timpl R. Collagen type VI in the human bone marrow microenvironment: A strong cytoadhesive component. Blood 86:1740-1748, 1995.
57. Soszka T, Knudsen KA, Beviglia L, Rossi C, Poggi A, Niewiarowski S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res 196:6-12, 1991.
58. Moore MAS, Phil D, Shapiro F. Regulation and function of hematopoietic stem cells. Curr Opin Hematol 1:180-186, 1994.
59. Tucker D, Bol S, Kannourakis G. Characterization of stroma-adherent colony-forming cells: A clonogenic assay for early hemopoietic cells? Exp Hematol 21:469-474, 1993.
60. Lowry PA, Deacon D, Whitefield P, McGrath HE, Quesenberry PJ. Stem cell factor induction on in vitro murine hematopoietic colony formation by "subliminal" cytokine combinations: The role of "anchor factors." Blood 80:663-669, 1992.
61. Nathan C, Sporn M. Cytokines in context. J Cell Biol 113:981-986, 1991.
62. Shima M, Teitelbaum SL, Holers VM, Ruzicka C, Osmack P, Ross FP. Macrophage-colony-stimulating factor regulates expression of the integrins alpha 4 beta 1 and alpha 5 beta 1 by murine bone marrow macrophages. Proc Natl Acad Sci USA 92:5179-5183, 1995.
63. Lowry PA. Hematopoietic stem cell cytokine response. J Cell Biochem 58:410-415, 1995.
64. Teshima T, Harada M, Takamatsu Y, Makino K, Taniguchi S, Inaba S, Kondo S, Tanaka T, Akashi K, Minamishima I, Ishii E, Nishimura J, Niho Y. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant 10:215-220, 1992.
65. Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709-1719, 1993.
66. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031-2135, 1993.
67. 4 integrin. Proc Natl Acad Sci USA 90:9374-9378, 1993.
68. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352:438-441, 1991.
69. Minguell JJ, Hardy CH, Tavassoli M. Adhesive interaction of hemopoietic progenitor cell membrane with the RGD domain of fibronectin. Biochim Biophys Acta 1151:120-126, 1993.
70. Hardy CL, Minguell JJ. Modulation of the adhesion of hemopoietic progenitor cells to the RGD site of fibronectin by interleukin 3. J Cell Physiol 164:315-323, 1995.
71. + hemopoietic progenitor cells. J Immunol 153:4673-4683, 1994.
72. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
73. 2 integrins on lymphokine-activated killer cells. Eur J Immunol 23:2464-2471, 1993.
74. McNiece IK, Briddel RA, Hartley CA, Smith KA, Andrews RG. Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells 11(Suppl 2):36-41, 1993.
75. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760-3764, 1993.
76. 1 integrins expressed on hematopoietic cell lines. Blood 85:159-167, 1995.
77. Carlo-Stella C, Rizzoli V. Stem cells and stem cell factor(s). Hematologica 80:1-4, 1995.
78. Arnaout MA, Wang EA, Clark SC, Sieff CA. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest 78:597-601, 1986.
79. Devereux S, Bull HA, Campos-Costa D, Saib R, Linch DC. Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: in-vitro and in-vivo studies in man. Brit J Haematol 71:323-330, 1989.
80. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myelogenous leukaemia. Nature 328:342-344, 1987.
81. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 90:1232-1239, 1992.
82. Bhatia R, Wayner EA, McGlave PB, Verfaillie CM. Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J Clin Invest 94:384-391, 1994.
83. Bhatia R, McGlave PB, Verfaillie CM. Treatment of marrow stroma with interferon-α restores normal β1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1α. J Clin Invest 96:931-939, 1995.
84. Pfeffer LM, Eisenkraft BL, Reich NC, Improta T, Baxter G, Daniel-Issakani S, Strulovki B. Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 88:7988-7992, 1991.
85. Languino LR, Ruoslahti E. An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J Biol Chem 267:7116-7129, 1992.
86. 1c. Science 269:1570-1571, 1995.
87. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63:245-247, 1990.
88. van der Loo JCM, Ploemacher RE. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85:2598-2606, 1995.
89. Fabian I, Bleiberg I, Riklis I, Kletter Y. Enhanced reconstitution of hematopoietic organs in irradiated mice, following their transplantation with bone marrow cells pretreated with recombinant interleukin 3. Exp Hematol 15:1140-1144, 1987.
90. Tavassoli M, Konno M, Shiota Y, Omoto E, Minguell JJ, Zanjani DE. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 77:1599-1606, 1991.
91. Shiota Y, Minguell J, Zanjani ED, Tavassoli M. Induction of upmodulation of homing receptors in cloned hemopoietic progenitors by growth factors. Bone Marrow Transplant 9:123-127, 1992.
92. Minguell JJ, Hardy C. Restorative effect of IL-3 on adherence of cloned hemopoietic progenitor cells to stromal cell. Exp Hematol 21:55-60, 1993.
93. Williams GT, Smith AC, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony-stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79, 1990.
94. Minguell JJ, Tavassoli M. Proteoglycan synthesis by hemopoietic progenitor cells. Blood 73:1821-1827, 1989.
95. Shirota T, Minguell JJ, Tavassoli M. Expression of chondroitin sulfate as a unique type of proteoglycan on the cell membrane of multipotential and committed hemopoietic progenitor cells. Biochim Biophys Acta 1136:17-22, 1992.
96. Conget P, Minguell JJ. IL-3 increases surface proteoglycan synthesis in haemopoietic progenitors and their adhesiveness to the heparin-binding domain of fibronectin. Brit J Haematol 89:1-7, 1995.
97. Drize N, Chertkov J, Zander A. Hematopoietic progenitor cells mobilization into the peripheral blood of mice using a combination of recombinant stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Exp Hematol 23:1180-1186, 1995.
98. Orazi A, Cattoretti G, Schiró R, Siena S, Bregni M, Di Nicola M, Gianni AM. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: Effect on hematopoiesis and microenvironment in human bone marrow. Blood 79:2610-2619, 1992.
99. Bussolino F, Ziehe M, Wang JM, Alessi D, Morbidelli L, Cremona O, Bosia A, Marchisio PC, Mantovani A. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 87:986-995, 1991.
100. Schweitzer CM, van der Schoot CE, Dräger AM, van der Valk P, Zevenbergen A, Hooibrink B, Westra AH, Langenhuijsen MMAC. Isolation and culture of human bone marrow endothelial cells. Exp Hematol 23:41-48, 1995.
101. Huss R, Hoy CA, Deeg HJ. Contact-and growth factor-dependent survival in a canine marrow-derived stromal cell line. Blood 85:2414-2421, 1995.
102. Dedhar S, Gaboury L, Galloway P, Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 85:9253-9257, 1988.
103. Simmons PJ, Masinovsky B, Longhenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388-395, 1992.
104. Juneja HS, Schmalsteig FC, Lee S, Chen J. Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol 21:444-450, 1993.
105. Thornhill MH, Haskard DO. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol 145:865-872, 1990.
106. Keller U, Aman MJ, Derigs G, Huber C, Peschel C. Human interleukin-4 enhances stromal cell-dependent hematopoiesis: Costimulation with stem cell factor. Blood 84:2189-2196, 1994.
107. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest 95:264-271, 1995.
108. Abboud CN. Human bone marrow microvascular endothelial cells: Elusive cells with unique structural and functional properties. Exp Hematol 23:1-3, 1995.
109. Masek LC, Sweetenham JW. Isolation and culture of endothelial cells from human bone marrow. Brit J Haematol 88:855-865, 1994.
110. Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F, Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: Selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84:1913-1921, 1994.
111. Brizzi MF, Garbarino G, Rossi PR, Pagliardi GL, Arduino C, Avanzi GC, Pegoraro L. Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest 91:2887-2892, 1993.
112. Meng H, Tonnesen MG, Marchese MJ, Clark RAF, Bahou WF, Gruber BL. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Physiol 165:40-53, 1995.
113. Romer LH, Mclean NV, Yan HC, Daise M, Sun J, DeLisser Hm. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol 154:6582-6592, 1995.
114. Klein CL, Bittinger F, Koehler H, Wagner M, Otto M, Hermanns I, Kirkpatrick CJ. Comparative studies on vascular endothelium in vitro. 3. Effects of cytokines on the expression of E-selectin, ICAM-1 and VCAM-1 by cultured endothelial cells obtained from different passages. Pathobiology 63:83-92, 1995.
115. Turner RR, Beckstead JH, Warnke RA. Endothelial cell phenotypic diversity. Am J Clin Pathol 87:569-573, 1987.
116. Hansen PB, Knudsen H, Gaarsdal E, Jensen L, Ralfkiaer E, Johnsen HE. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 16:373-379, 1995.
117. Kimura A, Katoh O, Hyodo H, Kuramoto A. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol 72:486-491, 1989.
118. Sakai T, Ohta M, Furukawa Y, Saga Y, Aizawa S, Kawakatsu H, Saito M. Tenascin-C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions. J Cell Physiol 165:18-29, 1995.
119. Ramasamy S, Lipke DW, McClain CJ, Hennig B. Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J Cell Physiol 162:119-126, 1995.
120. Bruno E, Luikart SD, Long MW, Hoffman R. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 23:1212-1217, 1995.
121. Colombatti A, Bonaldo P. The super family of proteins with von Willebrand Factor type A-like domains: One theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77:2305-2315, 1991.
122. Siczkowski M, Amos ATS, Gordon MY. Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures. Exp Hematol 21:126-130, 1993.
123. Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6:1349-1365, 1995.
124. Yang L, Yang YC. Heparin inhibits the expression of interleukin-11 and granulocyte-macrophage colony-stimulating factor in primate bone marrow stromal fibroblasts through mRNA destabilization. Blood 86:2526-2533, 1995.
125. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823-831, 1994.
126. Christiansen I, Gidlof C, Wallgren AC, Simonson B, Totterman TH. Serum levels of soluble intercellular adhesion molecule-1 are increased in chronic lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood 84:3010-3016, 1984.
127. Akan H, Sengul S, Beksac M, Koc H, Ilham O, Gurman G, Ozcan M. Soluble adhesion molecules during progenitor cell engraftment. Blood 86:975a, 1995.
128. Minguell JJ. Is hyaluronic acid the "organizer" of the extracellular matrix in marrow stroma? Exp Hematol 21:7-8, 1993.
129. Taniguchi Y, Komatsu N, Moriuchi T. Overexpression of the HOX4A (HOXD3) homeobox gene in human erythroleukemia HEL cells results in altered adhesive properties. Blood 85:2786-2794, 1995.
130. Huang N, Kawano MM, Mahmoud MS, Mihara K, Tsujimoto T, Niwa O, Kuramoto A. Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells. Blood 85:3704-3712, 1995.
131. Petropavlovskaia MS, Roberts SJ, Elwood PC. TGF-β1 and retinoic acid induce the adherence of leukemic cells to bone marrow stroma. Blood 86:26a, 1995.
132. Kimura A, Kawaishi K, Katoh O, Kuramoto A, Satow Y. L-selectin expression on CD34 positive cells is decreased in chronic myelocytic leukemia (CML). Blood 86:524a, 1995.
133. De Kossodo S, Moore R, Gschmeissner S, East N, Upton C, Balkwill FR. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis. Br J Cancer 72:1165-1172, 1995.
134. Bodine DM, Seidel EN, Zsebo KM, Orlik D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445-455, 1993.
135. Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T, Tanaka J, Fujii Y, Kobayashi M, Kasai M, Sakurada K, Miyazaki T. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-γ, and tumor necrosis factor-α in graft-versus-host disease. Bone Marrow Transplant 13:745-751, 1994.
136. Antin JH, Ferrara JI. Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964-2968, 1992.